Will you have Decreased consciousness with Dotarem - from FDA reports


Decreased consciousness is found among people who take Dotarem, especially for people who are male, 50-59 old , have been taking the drug for < 1 month, also take medication Rhinocort, and have Nuclear magnetic resonance imaging brain. This study is created by eHealthMe based on reports of 1,250 people who have side effects when taking Dotarem from FDA, and is updated regularly.

What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on gadoterate meglumine (the active ingredients of Dotarem) and Dotarem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Decreased consciousness are also considered in the study.

What is Dotarem?

Dotarem has active ingredients of gadoterate meglumine. (latest outcomes from Dotarem 1,250 users)

What is Decreased consciousness?

Decreased consciousness has been reported by people with pain, depression, multiple sclerosis, high blood pressure, diabetes (latest reports from 37,963 Decreased consciousness patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

On Mar, 01, 2019

1,250 people reported to have side effects when taking Dotarem.
Among them, 7 people (0.56%) have Decreased consciousness

Number of reports submitted per year:

Could Dotarem cause Decreased consciousness?

Time on Dotarem when people have Decreased consciousness *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Decreased consciousness when taking Dotarem *:

  • female: 28.57 %
  • male: 71.43 %

Age of people who have Decreased consciousness when taking Dotarem *:

  • 0-1: 0.0 %
  • 2-9: 14.29 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 14.29 %
  • 40-49: 28.57 %
  • 50-59: 28.57 %
  • 60+: 14.29 %

Top conditions involved for these people *:

  1. Nuclear Magnetic Resonance Imaging Brain: 3 people, 42.86%
  2. Migraine With Aura (headache with vision weakness): 2 people, 28.57%
  3. Encephalitis (inflammation of the brain): 1 person, 14.29%

Top co-used drugs for these people *:

  1. Rhinocort: 2 people, 28.57%
  2. Zovirax: 1 person, 14.29%
  3. Ventolin: 1 person, 14.29%
  4. Pantoprazole: 1 person, 14.29%
  5. Claforan: 1 person, 14.29%
  6. Brintellix: 1 person, 14.29%

Top other side effects for these people *:

  1. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 5 people, 71.43%
  2. Acute Kidney Failure: 2 people, 28.57%
  3. Tonic Clonic Movements (generalized seizure that affects the entire brain): 2 people, 28.57%
  4. Cardiac Arrest: 2 people, 28.57%
  5. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 2 people, 28.57%
  6. Nausea And Vomiting: 2 people, 28.57%
  7. Hepatic Failure (liver failure): 1 person, 14.29%
  8. Arrhythmias (irregular heartbeat): 1 person, 14.29%
  9. Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 1 person, 14.29%
  10. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you have Decreased consciousness while taking Dotarem?

You are not alone:

Related studies

Drugs that are associated with Decreased consciousness
Decreased consciousness (2,375 drugs)
Could your condition cause Decreased consciousness
Decreased consciousness (2,449 conditions)
Dotarem side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dotarem
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Dotarem and have Decreased consciousness

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.